J. Ironside
- Genetics top 5%
- Virus-based gene therapy research 1
- Biotechnology top 5%
- Oncology top 5%
- Lung Cancer Research Studies 2
- CAR-T cell therapy research 1
- Otorhinolaryngology top 10%
-
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Brain Metastases and Treatment 1
-
- Neuroendocrine Tumor Research Advances 1
-
- Childhood Cancer Survivors' Quality of Life 1
- Co-authors
- R.H. MacDougallAnn M. GillenwaterDavid H. KirnPatricia A. BrusoFadlo R. KhuriIan GanlyCarla HeiseIan F. Tannock
- Cited by
- GeneticsBiotechnologyOncology
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Radiotherapy and Oncology (1 paper)Clinical Oncology (1 paper)
- Partner nations
- United KingdomNew ZealandUnited States
In The Last Decade
J. Ironside
7 papers receiving 882 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Genetics 708
- Biotechnology 180
- Oncology 538
- Otorhinolaryngology 48
- Molecular Biology 583
Countries citing papers authored by J. Ironside
This map shows the geographic impact of J. Ironside's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ironside with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ironside more than expected).
Fields of papers citing papers by J. Ironside
This network shows the impact of papers produced by J. Ironside. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ironside. The network helps show where J. Ironside may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. Ironside, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 14 | |
| 2 | 2008 | 24 | |
| 3 | 2007 | 3 | |
| 4 | 2005 | 1 | |
| 5 | 2004 | 13 | |
| 6 | A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerbreakdown → | 2000 | 858 |
| 7 | 1987 | 3 |
About J. Ironside
J. Ironside is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Radiation and Genetics, having authored 7 papers that have together received 916 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Research Studies (2 papers), Virus-based gene therapy research (1 paper), Neuroendocrine Tumor Research Advances (1 paper), CAR-T cell therapy research (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Genetics (708 citations), Biotechnology (180 citations), Oncology (538 citations), Otorhinolaryngology (48 citations) and Molecular Biology (583 citations). J. Ironside has collaborated with scholars based in United Kingdom, New Zealand and United States. Frequent co-authors include R.H. MacDougall, Ann M. Gillenwater, David H. Kirn, Patricia A. Bruso, Fadlo R. Khuri, Ian Ganly, Carla Heise, Ian F. Tannock, James C. Arseneau and John Nemunaitis. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Clinical Oncology, Nature Medicine and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.